Company Executives

$ Management Team

Name / Title	Age	Compensation	Sex	Social Media

Board of Directors

From the proxy statement filed Apr 18, 2025

Directors

serving now

Independent

8 of 9

stated in the proxy

Average tenure

8.0 years

from year joined

CEO also chairs the board

Anthony S. Gibney

Director	Age	On board	Independent	Committees	Other public boards	2024 pay
George Lasezkay CEO	73	2017 8 years	Not independent	None stated	None stated	Paid as CEO
Christy L. Shaffer	67	2012 13 years	Independent	None stated	None stated	Not stated
Anthony S. Gibney Board chair	54	2024 1 year	Independent	Audit Committee	None stated	$146,609
Jeffrey L. Edwards	64	2018 7 years	Independent	Audit Committee	FibroGen, Inc., Bio-Rad Laboratories, Inc.	$98,549
Clay B. Thorp	56	2012 13 years	Independent	None stated	None stated	$117,716
Benjamin R. Yerxa	59	2022 3 years	Independent	None stated	None stated	Not stated
Richard Croarkin	70	2016 9 years	Independent	Audit Committee · Chair	None stated	$101,049
William D. Humphries	58	2012 13 years	Independent	None stated	Aclaris Therapeutics, Inc.	$81,049
Nancy J. Hutson	75	2020 5 years	Independent	None stated	BioCryst Pharmaceuticals, Inc.	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 18, 2025

Bradford T. Whitmore

owns more than 5% of our common stock, together with his affiliates

$599,999.40

February 6, 2024

Purchased shares of common stock and warrants in the Company's February 2024 registered direct offering

Open in proxy

William D. Humphries

one of our directors; served as Chief Executive Officer of Alcami from June 2023 to January 2025

Approximately $1.5 million and $0.8 million

year ended December 31, 2023 and December 31, 2024

Master Services Agreement under which Alcami provides manufacturing services to the Company; Company paid Alcami for services

With Alcami Corporation, Inc. Open in proxy

Comments

Company Executives

$ Management Team

Board of Directors

Related-party transactions